Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Apr 14;117(15):e131-41.
doi: 10.1182/blood-2010-10-316224. Epub 2011 Feb 17.

High-resolution kinetics of cytokine signaling in human CD34/CD117-positive cells in unfractionated bone marrow

Affiliations

High-resolution kinetics of cytokine signaling in human CD34/CD117-positive cells in unfractionated bone marrow

Philip G Woost et al. Blood. .

Abstract

Cytokine-mediated phosphorylation of Erk (pErk), ribosomal S6 (pS6), and Stat5 (pStat5) in CD34(+)/CD117(+) blast cells in normal bone marrow from 9 healthy adult donors were analyzed over 60 minutes. Treatment with stem cell factor (SCF), Flt3-ligand (FL), IL-3, and GM-CSF and measurement by multiparametric flow cytometry yielded distinctive, highly uniform phosphoprotein kinetic profiles despite a diverse sample population. The correlated responses for SCF- and FL-stimulated pErk and pS6 were similar. Half the population phosphorylated Erk in response to SCF between 0.9 and 1.2 minutes, and S6 phosphorylation followed approximately a minute later (t½(pS6 rise) = 2.2-2.7 minutes). The FL response was equally fast but more variable (t½(pErk rise) = 0.9-1.3 minutes; t½(pS6 rise) = 2.5-3.5 minutes). Stat5 was not activated in 97% of the cells by either cytokine. IL-3 and GM-CSF were similar to each other with half of blast cells phosphorylating Stat5 and 15% to 20% responding through Erk and S6. Limited comparison with leukemic blasts confirmed universal abnormal signaling in AML that is significantly different from normal bone marrow blasts. These differences included sustained signals, a larger fraction of responding cells, and amplification of phosphorylation levels for at least one phosphoprotein. These data support the eventual use of this approach for disease diagnosis and monitoring.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Gating strategy for pErk, pS6, and pStat5 in CD34+, CD117+ blast cells. (A) A region used to exclude debris. (B) The circle represents the blast region defined by CD45 expression and side scatter. (C) The box shows the CD34+/CD117+ region. (D,G) pErk histograms at t = 0 (gray) or 2 (green) minutes for SCF and t = 0 (gray) or 8 (green) minutes for IL-3, respectively. (E,H) pS6 histograms at t = 0 (gray) or 4 (blue) minutes for SCF and t = 0 (gray) or 8 (blue) minutes for IL-3, respectively. (F,I) pStat5 histograms at t = 0 (gray) or 2 (red) minutes for SCF and t = 0 (gray) or 8 (red) minutes for IL-3, respectively. The histograms are representative of all the flow cytometry data reported here.
Figure 2
Figure 2
Cytokine-mediated phosphoprotein kinetic profiles: frequency. Frequency indicates percentage of responding blast cells. Error bars represent SEM.
Figure 3
Figure 3
SCF- and FL-mediated Erk and S6 signal shape analysis. Response indicates percentage of responding cells with t = 0 level subtracted. Individual signaling profiles were normalized to t = 0 (equal to 0 response) and the largest value (maximum). t½Erk/S6 rise indicates time to 50% of maximum; and t½Erk/S6 decay, time to 50% loss of maximum. Gray zones represent 95% CI for t½Erk rise (A-B) and t½Erk decay (C). The response shapes for S6 phosphorylation were not significantly different (D). Error bars represent 95% CI.
Figure 4
Figure 4
IL-3– and GM-CSF–mediated Stat5, Erk, and S6 signal shape comparisons. Response indicates percentage of responding cells with t = 0 level subtracted. Error bars represent SEM. Data were processed as described in the legend to Figure 3.
Figure 5
Figure 5
Cytokine-mediated phosphoprotein kinetic profiles: MFI. Error bars represent SEM.
Figure 6
Figure 6
Phosphoprotein kinetic profiles of AML patient samples: frequency analysis. (A-B) The frequency of blast cells that are not positive for any of the 3 downstream markers are plotted with the frequency at t = 0 set to 100%. (C-F) Actual frequencies (in percentage) of cells positive for each marker at time t. Gray zones represent 95% CI for normal blast cell response; and black line, the center (mean) of that distribution. Arrows point to high constitutive activity for AML3. ⟐ represents AML2; □, AML3; ⊠, AML1; ⊡, AML5; and ▒, NBM.
Figure 7
Figure 7
Phosphoprotein kinetic profiles of AML patient samples: MFI analysis. AMLs classified as 3 potential “phenotypes” by signaling patterns: AML3 (rows A and J); AMLs 1 and 2 (rows D and M); AML5 (rows G and P). Data have been normalized to NBM for SCF → Erk, SCF → S6, and IL-3 → Stat5 = 1.0 at max. Colored zones represent the 95% CI for the NBM blast response MFIs.

References

    1. Lemmon MA, Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell. 2010;141(7):1117–1134. - PMC - PubMed
    1. Chow S, Hedley D, Grom P, Magari R, Jacobberger JW, Shankey TV. Whole blood fixation and permeabilization protocol with red blood cell lysis for flow cytometry of intracellular phosphorylated epitopes in leukocyte subpopulations. Cytometry A. 2005;67(1):4–17. - PubMed
    1. Muller C, Bonmann M, Cassens U, Koch OM. Flow cytometric analysis of protein phosphorylation in the hematopoietic system. Leuk Lymphoma. 1998;29(3):351–360. - PubMed
    1. Fleisher TA, Dorman SE, Anderson JA, Vail M, Brown MR, Holland SM. Detection of intracellular phosphorylated STAT-1 by flow cytometry. Clin Immunol. 1999;90(3):425–430. - PubMed
    1. Chow S, Patel H, Hedley DW. Measurement of MAP kinase activation by flow cytometry using phospho-specific antibodies to MEK and ERK: potential for pharmacodynamic monitoring of signal transduction inhibitors. Cytometry. 2001;46(2):72–78. - PubMed

Publication types

MeSH terms